Haruo Sekiguchi

Title: Haruo Sekiguchi: Innovator in Anti-Ulcer Urea Derivatives

Introduction

Haruo Sekiguchi is a notable inventor based in Ageo, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of anti-ulcer agents. With a total of 2 patents, Sekiguchi's work has had a meaningful impact on medical treatments.

Latest Patents

Sekiguchi's latest patents include innovative urea derivatives that serve as effective anti-ulcer agents. The first patent describes urea derivatives characterized by a specific formula, where R₂ indicates a piperidino or pyrrolidino group, which may be substituted with a hydroxy group or a lower alkyl group having 1 to 13 carbon atoms. The formula also includes various alkyl groups and functional groups that enhance the compound's efficacy. The second patent focuses on anti-ulcer urea derivatives, which similarly utilize a specific formula to create compounds that are beneficial in treating ulcers.

Career Highlights

Haruo Sekiguchi is currently employed at Kyorin Pharmaceutical Co., Ltd., where he continues to innovate in the pharmaceutical industry. His work has been instrumental in advancing the understanding and treatment of ulcer-related conditions.

Collaborations

Sekiguchi has collaborated with notable coworkers, including Hiroshi Matsukubo and Toyomi Matsumoto. Their combined expertise has contributed to the successful development of new pharmaceutical compounds.

Conclusion

Haruo Sekiguchi's contributions to the field of anti-ulcer agents through his innovative patents highlight his role as a significant inventor in the pharmaceutical industry. His work continues to influence medical treatments and improve patient outcomes.